로딩 중…
지수 로딩 중…
CMG Pharmaceutical Co., Ltd.
058820· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩1,007-5.89%
2026-06-19
Price Chart
CMG Pharmaceutical Co., Ltd.-52.05%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 148.88B KRW |
| Revenue | 110.12B KRW |
| Net Income | -8.38B KRW |
| Total Assets | 319.33B KRW |
| Net Assets | 201.72B KRW |
| Employees | 282 |
| Value | |
| P/B | 0.74x |
| P/S | 1.35x |
| FCF Yield | -27.30% |
| Profitability | |
| ROE | -4.16% |
| ROA | -2.63% |
| Op. Margin | -4.80% |
| Revenue Growth | 23.71% |
| Earnings Growth | -473.96% |
| Financial Health | |
| Debt Ratio | 58.30% |
| Total Debt | 88.05B KRW |
| FCF | -40.65B KRW |
| Cash | 9.18B KRW |
| Current Ratio | 1.25x |
| Performance | |
| 1Y Return | -52.05% |
| 1M Return | -26.98% |
| From 52W High | -56.59% |
| 1Y MDD | -55.64% |
| Trading | |
| Volume | 880,694 shares |
| Foreign Own. | 5.63% |
| Per Share | |
| EPS | -57 KRW |
| BPS | 1,364 KRW |
Company Info
CMG Pharmaceutical, established in 2001, merged Celltrate Pharm Korea in 2008 and now primarily focuses on the research, development, production, and sales of pharmaceuticals and health functional foods. The company applies oral disintegrating films, leveraging its core STARFILM Technology, to incrementally modified drugs and is expanding its product portfolio into new business sectors like anti-cancer drugs, anti-aging, and ophthalmology. CMG Pharmaceutical is actively pursuing revenue growth and market share expansion through new drug development, facilitated by US FDA product approvals and technology exports. The company is headquartered in Gangnam-gu, Seoul.